# Defective Lysosomal Lipolysis Causes Prenatal Lipid Accumulation and Exacerbates Immediately after Birth.

- **DOI:** [10.3390/ijms221910416](https://doi.org/10.3390/ijms221910416)
- **Rating:** Sound (3.4 out of 5)
- **Verdict:** Developmental profiling establishes prenatal lipid accumulation and rapid postnatal worsening in LAL-deficient mice, but overstates the absence of HSL-related effects.
- **Framework version:** v5.13
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-11-13
- **Evaluation page:** https://www.nabu.science/paper/10.3390%2Fijms221910416

## Key claims

1. defective lysosomal but not neutral lipolysis alters placental and fetal cholesterol homeostasis and exhibits an initial disease pathology already in utero as Lal-/- fetuses accumulate hepatic lysosomal lipids.
   - Support: Tentative
   - Type: Primary finding
   - Basis: the HSL comparison does not establish absence of metabolic effects, despite convergent evidence for prenatal LAL-associated lipid accumulation
   - Location: Abstract
2. Immediately after birth, LAL deficiency exacerbates with massive hepatic lysosomal lipid accumulation, which continues to worsen into young adulthood.
   - Support: Supported
   - Type: Secondary
   - Basis: age-specific measurements support worsening, although different animals and genotype-relative lipid values limit direct assessment of progression
   - Location: Abstract; Sections 2.5–2.6
3. HSL deficiency has little effect on placental and fetal development and does not interfere with placental lipid metabolism.
   - Support: Tentative
   - Type: Secondary
   - Basis: uncertain maternal comparability and changed placental gene expression prevent the negative comparison from establishing no metabolic effect
   - Location: Introduction, final paragraph; Section 2.2

## Strengths

- **Convergent measurements identify prenatal lipid accumulation** Lipid quantification, enzyme assays, lysosomal staining, and electron microscopy converge on prenatal abnormalities in LAL-deficient tissues. These complementary measurements support the central LAL phenotype.
  - Dimension: methodological rigour
  - Location: Results Sections 2.3–2.4; Methods Sections 4.4–4.7
- **Developmental sampling extends established disease models** Sampling at late gestation, two days, two weeks, and four weeks establishes an early-life disease profile beyond the adult phenotypes emphasized in prior mouse work.
  - Dimension: contribution
  - Location: Results Sections 2.3–2.6; Discussion
- **Discussion considers maternal and dietary influences** The interpretation explicitly considers active LAL supplied by heterozygous mothers and dietary changes around birth and weaning. Prenatal human case reports also place the mouse findings in clinical context.
  - Dimension: positioning
  - Location: Discussion

## Limitations

- **Bias safeguards and replicate units remain unclear** Blinded assessment of histology and electron microscopy is not reported. The statement that samples came from different dams does not explicitly define the statistical unit or explain handling of multiple littermates.
  - Dimension: methodological rigour
  - Location: Methods Sections 4.1, 4.4, 4.7–4.8
- **HSL no-effect wording exceeds measured evidence** The broad claim that HSL deficiency does not interfere with placental lipid metabolism exceeds the unchanged lipid concentrations: neutral CE hydrolase activity fell 35%, and cholesterol-synthesis gene expression fell more than 50%.
  - Dimension: reporting
  - Location: Abstract; Introduction, final paragraph; Results Section 2.2
- **HSL controls lack established maternal comparability** The reported HSL breeding cross cannot produce wild-type offspring, leaving the source of wild-type comparators and their maternal comparability unresolved. This limits interpretation of the negative HSL comparison.
  - Dimension: methodological rigour
  - Location: Methods Section 4.1; Results Section 2.2

## Reliability checks

No concerns (4 of 4 checks).

- **Results check:** Clean. The reported numbers and statistics are consistent with the stated results.
- **Reporting and transparency:** Clean. Animal ethics approval is declared with permit identifiers. Explicitly unshown and unpublished observations limit verification but do not independently establish a conduct concern.
  - Ethics approval: declared
- **Reference integrity:** Clean. 48 of 48 checkable references verified
  - 48 references in manuscript
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-11-13
